EP1718285A2 - USE OF A COMPOUND MODULATING AT LEAST ONE RECEIVER SELECTED IN A GROUP COMPRISING AN INTERLEUKIN 8 TYPE B RECEPTOR AND PACAP-1 RECEPTOR FOR PREPARING A PHARMACEUTICAL COMPOSITION FOR ROSACEA TREATMENT